Clavis Pharma names new CEO
This article was originally published in Scrip
The Norwegian cancer drug development company Clavis Pharma has named Olav Hellebø chief executive officer. Mr Hellebø joins from UCB, where he was senior vice-president of UCB Pharma and president of immunology operations. He will take up his position at Clavis on February 1st.